Literature DB >> 20483196

Cholera vaccines: WHO position paper-Recommendations.

.   

Abstract

This article presents the WHO recommendations on the use of cholera vaccines excerpted from the recently published Cholera vaccines: WHO position paper. This document replaces the WHO position paper on Cholera vaccines published in the Weekly Epidemiological Record in April 2001. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO's Strategic Advisory Group of Experts on immunization (SAGE). Copyright 2010. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483196     DOI: 10.1016/j.vaccine.2010.05.008

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

2.  Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Authors:  Taher Uddin; Amena Aktar; Peng Xu; Russell A Johnson; M Arifur Rahman; Daniel T Leung; Sadia Afrin; Aklima Akter; Mohammad Murshid Alam; Atiqur Rahman; Fahima Chowdhury; Ashraful I Khan; Taufiqur Rahman Bhuiyan; Meagan K Bufano; Rasheduzzaman Rashu; Yanan Yu; Ying Wu-Freeman; Jason B Harris; Regina C LaRocque; Richelle C Charles; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

3.  Role of 6-gingerol in reduction of cholera toxin activity in vitro and in vivo.

Authors:  Pallashri Saha; Bornita Das; Keya Chaudhuri
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

Review 4.  Crossing borders: one world, global health.

Authors:  Christina R Phares; Luis Ortega
Journal:  Clin Infect Dis       Date:  2014-01       Impact factor: 9.079

5.  Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh.

Authors:  Fahima Chowdhury; Mohammad Arif Rahman; Yasmin A Begum; Ashraful I Khan; Abu S G Faruque; Nirod Chandra Saha; Nabilah Ibnat Baby; M A Malek; Anisha Rajeev Kumar; Ann-Mari Svennerholm; Mark Pietroni; Alejandro Cravioto; Firdausi Qadri
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

6.  Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

Authors:  Richelle C Charles; Isabelle J Hilaire; Leslie M Mayo-Smith; Jessica E Teng; J Gregory Jerome; Molly F Franke; Amit Saha; Yanan Yu; Paul Kováč; Stephen B Calderwood; Edward T Ryan; Regina C LaRocque; Charles P Almazor; Firdausi Qadri; Louise C Ivers; Jason B Harris
Journal:  PLoS Negl Trop Dis       Date:  2014-05-01

7.  A retrospective analysis of oral cholera vaccine use, disease severity and deaths during an outbreak in South Sudan.

Authors:  Cavin Epie Bekolo; Joris Adriaan Frank van Loenhout; Jose Manuel Rodriguez-Llanes; John Rumunu; Otim Patrick Ramadan; Debarati Guha-Sapir
Journal:  Bull World Health Organ       Date:  2016-06-14       Impact factor: 9.408

8.  Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014.

Authors:  Heather M Scobie; Christina R Phares; Kathleen A Wannemuehler; Edith Nyangoma; Eboni M Taylor; Anna Fulton; Nuttapong Wongjindanon; Naw Rody Aung; Phillipe Travers; Kashmira Date
Journal:  PLoS Negl Trop Dis       Date:  2016-12-19

9.  The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.

Authors:  Andrew S Azman; Francisco J Luquero; Iza Ciglenecki; Rebecca F Grais; David A Sack; Justin Lessler
Journal:  PLoS Med       Date:  2015-08-25       Impact factor: 11.069

Review 10.  Oral Cholera Vaccination Delivery Cost in Low- and Middle-Income Countries: An Analysis Based on Systematic Review.

Authors:  Vittal Mogasale; Enusa Ramani; Hyeseung Wee; Jerome H Kim
Journal:  PLoS Negl Trop Dis       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.